Barbara Ruby

Barbara Ruby


Ms. Barbara Ruby has been involved in clinical research since the early 1990s, working as both a study coordinator and sub-investigator (rater) at sites. In 1997, she started working as a clinical research associate who monitors the clinical trials at study sites and then moved into the role of project manager in the early 2000s.  She has worked at small biotech companies and small and large CROs (clinical research organizations).  She currently works as an oversight director, overseeing the project managers and clinical trials at PPD, part of Thermo Fisher Scientific.

Ms. Ruby started working in the Mast Cell Disease Society (TMS) in the advocacy group where she served as the chair after the former chair had to step down.  She has also volunteered on the Research Committee and assisted with the needs assessment questionnaire.

Ms. Ruby came onto the board at TMS in early 2022 and is current performing in the role of secretary on the board of directors.

Ms. Ruby was diagnosed with Systemic Mastocytosis in early 2013 after having symptoms for 9 years.  She is excited to bring her knowledge and experience in clinical trials to TMS and to support the development of new drugs to treat systemic mastocytosis and mast cell diseases.

Back to Board List